![René Muttenzer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van René Muttenzer
Eerdere bekende functies van René Muttenzer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACINO HOLDING AG | Directeur/Bestuurslid | 17-11-2009 | 31-03-2012 |
NOVARTIS AG | Corporate Officer/Principal | - | - |
Posbelduf Biotech AG
![]() Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Directeur/Bestuurslid | 03-03-2011 | - |
SPEXIS AG | Directeur/Bestuurslid | 17-11-2009 | - |
Opleiding van René Muttenzer
University of Basel | Graduate Degree |
Statistieken
Internationaal
Zwitserland | 6 |
Operationeel
Director/Board Member | 3 |
Graduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SPEXIS AG | Health Technology |
NOVARTIS AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Acino International AG
![]() Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Posbelduf Biotech AG
![]() Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Health Technology |
- Beurs
- Insiders
- René Muttenzer
- Ervaring